Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target
Open Access
- 27 January 2021
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 35 (4) , 1037-1052
Abstract
Progression of chronic lymphocytic leukemia (CLL) results from the expansion of a small fraction of proliferating leukemic B cells. When comparing the global gene expression of recently divided CLL cells with that of previously divided cells, we found higher levels of genes involved in regulating gene expression. One of these was the oncogene Musashi 2 (MSI2), an RNA-binding protein that induces or represses translation. While there is an established role for MSI2 in normal and malignant stem cells, much less is known about its expression and role in CLL. Here we report for the first time ex vivo and in vitro experiments that MSI2 protein levels are higher in dividing and recently divided leukemic cells and that downregulating MSI2 expression or blocking its function eliminates primary human and murine CLL and mature myeloid cells. Notably, mature T cells and hematopoietic stem and progenitor cells are not affected. We also confirm that higher MSI2 levels correlate with poor outcome markers, shorter time-to-first-treatment, and overall survival. Thus, our data highlight an important role for MSI2 in CLL-cell survival and proliferation and associate MSI2 with poor prognosis in CLL patients. Collectively, these findings pinpoint MSI2 as a potentially valuable therapeutic target in CLL.Keywords
This publication has 62 references indexed in Scilit:
- Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signalingProceedings of the National Academy of Sciences, 2013
- TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIAMediterranean Journal of Hematology and Infectious Diseases, 2012
- Musashi expression in β-cells coordinates insulin expression, apoptosis and proliferation in response to endoplasmic reticulum stress in diabetesCell Death & Disease, 2011
- Musashi 2 is a regulator of the HSC compartment identified by a retroviral insertion screen and knockout miceBlood, 2011
- The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemiaBlood, 2011
- Regulation of myeloid leukaemia by the cell-fate determinant MusashiNature, 2010
- Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaNature Medicine, 2010
- Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cellsBlood, 2010
- High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL diseaseBlood, 2010
- Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferationHaematologica, 2009